Pazopanib as third-line therapy for metastatic renal cell carcinoma: Clinical efficacy and temporal analysis of cytokine profile

被引：0
|
作者：
Pal, Sumanta K. [1 ]
Hossain, Dewan Md Sakib [1 ]
Zhang, Qifang [1 ]
Gao, Chan [1 ]
Jones, Jeremy O. [1 ]
Frankel, Paul H. [1 ]
Figlin, Robert A. [2 ]
Kortylewski, Marcin [1 ]
机构：
[1] City Hope Natl Med Ctr, Ctr Comprehens Canc, Duarte, CA USA
[2] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA
来源：
CANCER RESEARCH | 2014年 / 74卷 / 19期
关键词：
D O I：
10.1158/1538-7445.AM2014-CT334
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
CT334
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Pazopanib as a second-line treatment for non-cytokine-treated metastatic renal cell carcinoma: a meta-analysis of the effect of treatment
    Kok, Victor C.
    Kuo, Jung-Tsung
    BMC UROLOGY, 2016, 16
  • [42] Pazopanib as a second-line treatment for non-cytokine-treated metastatic renal cell carcinoma: a meta-analysis of the effect of treatment
    Victor C. Kok
    Jung-Tsung Kuo
    BMC Urology, 16
  • [43] Liver toxicity in patients with metastatic renal cell carcinoma treated with pazopanib therapy
    Lim, L.
    Mathias, J.
    Lampron, M.
    Fehr, M.
    Gruenwald, V.
    Khan, M.
    Crabb, S.
    Choueiri, T.
    Powles, T.
    Rini, B.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S660 - S660
  • [44] Retrospective Analysis of Fifth-Line Targeted Therapy Efficacy in Patients with Metastatic Renal Cell Carcinoma
    Ralla, Bernhard
    Erber, Barbara
    Goranova, Irena
    Klooker, Amelie
    Maxeiner, Andreas
    Hinz, Stefan
    Kempkensteffen, Carsten
    Magheli, Ahmed
    Miller, Kurt
    Busch, Jonas
    UROLOGIA INTERNATIONALIS, 2017, 98 (02) : 184 - 190
  • [45] Efficacy of fourth-line targeted therapy in patients with metastatic renal cell carcinoma: a retrospective analysis
    Ralla, Bernhard
    Erber, Barbara
    Goranova, Irena
    von der Aue, Luise
    Floercken, Anne
    Hinz, Stefan
    Kempkensteffen, Carsten
    Magheli, Ahmed
    Miller, Kurt
    Busch, Jonas
    WORLD JOURNAL OF UROLOGY, 2016, 34 (08) : 1147 - 1154
  • [46] Efficacy of fourth-line targeted therapy in patients with metastatic renal cell carcinoma: a retrospective analysis
    Bernhard Ralla
    Barbara Erber
    Irena Goranova
    Luise von der Aue
    Anne Floercken
    Stefan Hinz
    Carsten Kempkensteffen
    Ahmed Magheli
    Kurt Miller
    Jonas Busch
    World Journal of Urology, 2016, 34 : 1147 - 1154
  • [47] Impact of concomitant acid suppressive therapy on pazopanib efficacy and dose reductions in patients with metastatic renal cell carcinoma
    Van De Sijpe, Greet
    Beuselinck, Benoit
    Van Nieuwenhuyse, Tine
    Poncelet, Roxanne
    Bechter, Oliver
    Albersen, Maarten
    Roussel, Eduard
    Baldewijns, Marcella
    Tack, Jan
    Spriet, Isabel
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2020, 76 (09) : 1273 - 1280
  • [48] Impact of concomitant acid suppressive therapy on pazopanib efficacy and dose reductions in patients with metastatic renal cell carcinoma
    Greet Van De Sijpe
    Benoit Beuselinck
    Tine Van Nieuwenhuyse
    Roxanne Poncelet
    Oliver Bechter
    Maarten Albersen
    Eduard Roussel
    Marcella Baldewijns
    Jan Tack
    Isabel Spriet
    European Journal of Clinical Pharmacology, 2020, 76 : 1273 - 1280
  • [49] LIVER TOXICITY IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA TREATED WITH PAZOPANIB THERAPY
    Lim, F. L.
    Shamash, J.
    Wilson, P.
    Powles, T.
    ANNALS OF ONCOLOGY, 2012, 23 : 290 - 290
  • [50] Efficacy of First-Line Targeted Therapy in Real-World Korean Patients with Metastatic Renal Cell Carcinoma: Focus on Sunitinib and Pazopanib
    Kim, Myung Soo
    Chung, Ho Seok
    Hwang, Eu Chang
    Jung, Seung Il
    Kwon, Dong Deuk
    Hwang, Jun Eul
    Bae, Woo Kyun
    Park, Jae Young
    Jeong, Chang Wook
    Kwak, Cheol
    Song, Cheryn
    Seo, Seong Il
    Byun, Seok-Soo
    Hong, Sung-Hoo
    Chung, Jinsoo
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2018, 33 (51)
12345